Correction: Retrospective Study on the Use of Brodalumab for Atopic Dermatitis Management: Real-World Insights - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: Retrospective Study on the Use of Brodalumab for Atopic Dermatitis Management: Real-World Insights

  • By

  • Nikolaos Stavropoulos

  • Daniel Myszkowski

  • Dennis Braß

  • Vasileios Dervenis

  • Effimia Poungoura

  • Eggert Stockfleth

  • February 6, 2026

Share

Objective:

To provide insights on the use of brodalumab for managing atopic dermatitis.

Approach:
    Key Findings:
    • Brodalumab is the correct medication discussed for atopic dermatitis management.
    Interpretation:

    The correction clarifies the focus of the study on brodalumab's effectiveness in real-world settings.

    Conclusion:

    The article has been updated to accurately reflect the medication under study.

    Sources:

Original Source(s)

Related Content